Healthcare Sector

Trevi Therapeutics

Market Cap: US$662.4m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

Immatics

Market Cap: US$655.2m

A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.

AnaptysBio

Market Cap: US$653.1m

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

Day One Biopharmaceuticals

Market Cap: US$646.7m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

Arbutus Biopharma

Market Cap: US$643.5m

A clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States.

Anavex Life Sciences

Market Cap: US$642.9m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

Simulations Plus

Market Cap: US$640.4m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

Claritev

Market Cap: US$632.0m

Provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.

Fulgent Genetics

Market Cap: US$630.8m

Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

Curaleaf Holdings

Market Cap: CA$863.4m

Produces and distributes cannabis products in the United States and internationally.

RxSight

Market Cap: US$621.3m

A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

Cogent Biosciences

Market Cap: US$619.8m

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Embecta

Market Cap: US$615.4m

A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

Tian'an Technology Group

Market Cap: US$614.5m

Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.

CeriBell

Market Cap: US$607.6m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

Sionna Therapeutics

Market Cap: US$603.6m

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

AbCellera Biologics

Market Cap: US$602.9m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

Regulus Therapeutics

Market Cap: US$599.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

Butterfly Network

Market Cap: US$593.5m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

Evolus

Market Cap: US$592.5m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

KalVista Pharmaceuticals

Market Cap: US$586.6m

A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

Iovance Biotherapeutics

Market Cap: US$584.4m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

PolyNovo

Market Cap: AU$905.0m

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

Taysha Gene Therapies

Market Cap: US$581.7m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

Avanos Medical

Market Cap: US$581.3m

A medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

ORIC Pharmaceuticals

Market Cap: US$580.8m

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms cancers in the United States.

Integral Diagnostics

Market Cap: AU$900.8m

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

Elite Pharmaceuticals

Market Cap: US$576.9m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

Keros Therapeutics

Market Cap: US$574.7m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

Maravai LifeSciences Holdings

Market Cap: US$573.0m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

Advanced Medical Solutions Group

Market Cap: UK£424.1m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

Xencor

Market Cap: US$569.4m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases, and cancer.

Bicycle Therapeutics

Market Cap: US$569.3m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

Delcath Systems

Market Cap: US$564.5m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Dianthus Therapeutics

Market Cap: US$559.3m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

LifeMD

Market Cap: US$554.9m

Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.